Company intelligence / Profile preview

Vessi Medical

Ownership: Private
Development stage: Phase 1

Overview

Vessi Medical has developed a minimally invasive, office-based cryotherapy system using a proprietary cryo spray for the ablation of urological tissue, primarily targeting non-muscle invasive bladder cancer. The technology is designed to reduce complications and side effects compared to traditional surgical approaches. The company is currently expanding R&D and conducting clinical studies in Israel and the US, aiming for regulatory clearance

Therapeutic areas: OncologyNephrology
Modalities: DeviceCryotherapy device (cryo spray)
Industry: Therapeutic Medical Devices

Partnerships

ALIVE Israel HealthTech Fund (investor/partner)

Beyond the preview

Go deeper on Vessi Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vessi Medical.

Explore the full profile